Category:

Disaster & Management

Lloyd’s calls for state-backed ‘Black Swan’ reinsurance

The Black Swan cover could be used to ensure payments after catastrophes such as a cyber attack or solar storm destroying critical infrastructure, as well as for pandemics, Lloyd’s said in a report published on Wednesday.

“Our concern is you solve for pandemic and you don’t solve for the next disaster,” Lloyd’s Chief Executive John Neal told Reuters.

read more

From Parkinson’s to peanut allergy, pandemic puts brakes on new drugs

Neurocrine Chief Executive Kevin Gorman said in an interview that many neurologists had been redirected to fighting the pandemic, leading to delaying Ongentys until later in 2020. The delay to Palforzia, Aimmune’s sole approved drug, means the company will not generate any revenue until later this year, prompting it to halt new hires in a bid to preserve its $370 million of cash.

read more

Bank of England tells banks & insurers to push on with climate risk analysis

The guide drawn up by the Climate Financial Risk Forum (CFRF),which was set up by the BoE and Britain’s Financial Conduct Authority last year, is the first of its kind and sets out how financial firms can analyze and disclose risks from climate change and spot opportunities for new consumer products.Sarah Breeden, the BoE’s co-chair of the CFRF, said firms should start on their analyses straight away using the guide that is based on best practice from firms

read more

Covid-19 Pandemic:Tally rises to 5,66,840, general and health insurers receive 28,000 claims for Rs 445 crore

With 18,522 people testing positive for coronavirus in a single day, India’s COVID-19 tally climbed to 5,66,840 on Tuesday while the death toll rose to 16,893 with 418 new fatalities, according to the Union Health Ministry data.

Recording nearly 4,000 cases in the last 24 hours, Tamil Nadu has surpassed Delhi to regain the second spot among the list of worst-hit states by the pandemic, while Karnataka also recorded more than 1,100 overtaking Haryana and Andhra Pradesh.

read more

Patanjali takes a u-turn; says never claimed to have made Covid-19 medicine

“Patanjali has never claimed to make corona medicine.Rather, corona patients have been cured with this medicine. The drug was made under the license issued by the Ayush Ministry,” stated the reply by Patanjali Ayurved CEO Acharya Balakrishna to the notice.

“We made the combination of Tulsi Giloy Ashwagandha at an advanced level and when the clinical trials were done on the patients of Covid-19, the coronavirus patients were cured. A conspiracy has been hatched against us and if the Ayush Ministry tells us to conduct clinical trials once again then we are ready to face it,” he added.

read more

Digital risks continue to be the most significant threats to business:FERMA Survey

Digital risks continue to be the most significant threats to business in the short (12 months) and medium-term (3 years). Cyber threats are the number 1 risk in both time frames, and data theft and fraud are growing in importance and stand at number 4 in the short term.

Uncertain economic growth appears as the number 2 threat short term (12 months) and number 3 medium term (3 years).

read more